Advertisement
The Body: The Complete HIV/AIDS Resource
Follow Us Follow Us on Facebook Follow Us on Twitter Download Our App
Professionals >> Visit The Body PROThe Body en Espanol
Read Now: TheBodyPRO.com Covers AIDS 2014

HIV Life >> Gay Men

Pages: 1
MICA_INC
Regular

Reged: 07/12/00
Posts: 25
Loc: INTERNATIONAL
NEW HIV/AIDS TREATMENT
      #9701 - 09/17/00 08:33 AM

SEEKING CLINICAL TRIALS SPONSORSHIP & VOLUNTEERS

We are trying to get HIV Groups & Organizations, Medical and Pharmaceutical Institutions, and Universities and the Medical & Scientific Communities aware, informed and interested in MM-1, so that they can consider and help to Sponsor the MM-1 Clinical Trials, in order to assist those Persons with HIV/AIDS to obtain the MM-1 HIV/AIDS Treatment FREE of CHARGE, IF they qualify and are in the sponsored MM-1 Clinical Trials Study?

MM-1 is the alternative, natural, safe and effective treatment for HIV/AIDS, used Internationally, since 1987 on over 10,000 patients. The Pre-Clinical and Clinical Trials Summary Results for MM-1 from 1987-1993 have been done by The Inventor and Developer of MM-1, Prof. Dr. Ahmed Shafik.

MM-1 has been listed in the USA Patent Office, since a USA Patent was applied for in 1989. A Continuation MM-1 Patent Application Review was applied for August 1992, and April 1994, and the MM-1 is still pending USA Patent Approval!

MM-1 is listed in the AmFAR HIV/AIDS Treatment Directory Vol. 2, No. 4, Feb. 1989, Vol. 6, No. 1, Sept. 30, 1992 and Vol. 7, No. 4 Jan.10, 1995, The International Directory of HIV Clinical Trials (by The Canadian HIV Trials Network), June, 1992, pages 78 & 79, and AIDS Treatment News, issue #57, May 20, 1988 and issue #189, Dec.17, 1993.

MM-1 is a code name of a product proved to have immunopotentiating properties. It is an in vivo stimulator of natural killer cells, macrophage-mediated cytotoxicity and B cell response.

MM-1 is an Antiviral and Immunopotentiating drug which has very low toxicity and a wide safety margin. It appears that MM-1 penetrates and destroys the virus cover, thus preventing its adsorption to cell membrane.

The MM-1 drug restores the underlying Immunodeficiency in AIDS patients to within normal levels, opportunistic infections improved during MM-1 therapy, with the exception of Kaposi Sarcoma (KS), which is not affected by the drug.

The Patients were able to return to their work and normal activities of living after treatment with MM-1, thus allowing Persons with HIV/AIDS, and their families to live out their lives in peace, comfort and dignity!

Perhaps you may be interested, and perhaps you may even be willing to assist us as well.

Would you be willing to Volunteer and assist us in getting HIV Groups, Agencies and Organizations, Medical and Pharmaceutical Institutions, Universities and the Medical and Scientific Communities aware, informed and interested in MM-1, so that they can Sponsor the MM-1 Clinical Trials, in order to assist those Persons with HIV/AIDS to obtain FREE Medical Treatment with The MM-1 (FREE of CHARGE), IF they qualify for the Clinical Trials Study? If so, then please give details. Thank You very much.

Regards, MICA, INC.


FOR MORE INFORMATION PLEASE

VISIT OUR SITE AT : http://www.aidshivtreatment.bizland.com and http://www.geocities.com/mm1eg

OR EMAIL US AT : mm1eg@aidshivtreatment.bizland.com



Post Extras: Remind Me!   Notify Moderator  
Anonymous
Unregistered

Re: NEW HIV/AIDS TREATMENT new
      #9747 - 09/18/00 02:05 AM

Blah Blah Blah more unscientific crap from AIDS careerists.



Post Extras: Remind Me!   Notify Moderator  
MICA_INC.
Unregistered

Re: NEW HIV/AIDS TREATMENT new
      #9749 - 09/18/00 03:52 AM

We are very sorry that you feel this way about something that does have Scientific substance, and which has been written up in the Scientific literature, in AIDS Treatment News Listings and which has been presented at International AIDS Conferences!

Perhaps you should Open & View our site and see for yourself that there is indeed Scientific documentation, justification and other information about the MM-1 Treatment and its promising results!

We are trying to get Sponsored Clinical Trials for the
MM-1, so that the MM-1 can be offered FOR FREE TO THOSE PERSONS accepted in THE MM-1 CLINICAL TRIALS!

MM-1 will be given FOR FREE in the Clinical Trials, so we are sincere, not AIDS careerists as you say! We are Public Health Professionals who care about this AIDS Pandemic!



Post Extras: Remind Me!   Notify Moderator  
Anonymous
Unregistered

Re: NEW HIV/AIDS TREATMENT new
      #10592 - 10/08/00 09:11 PM

Don't be a experimental animal for these corupt pharmecutcal money making, blood sucking evil entities.




Post Extras: Remind Me!   Notify Moderator  
MICA_INC
Regular

Reged: 07/12/00
Posts: 25
Loc: INTERNATIONAL
Re: NEW HIV/AIDS TREATMENT new
      #10627 - 10/09/00 03:23 PM

First of all, your statement is incorrect! We are NOT a Pharmaceutical Company. Next, MICA, Inc. has been trying to get the MM-1 treatment available for persons with HIV/AIDS for over twelve years now.

Unfortunately, the MM-1 does not make the high profits for the Pharmaceutical Companies like the other HIV/AIDS Medications do, and this has resulted in the MM-1 getting very little attention all these years!

The reason for this is because the MM-1 is a treatment which is only used for a two-three month period of time, with occasional annual boosters, if needed. That is why the MM-1 is not as profitable for the Pharmaceutical Companies as the other HIV/AIDS Medications (that must be taken every day for the rest of the life of the patient), and that is also why we are still trying to get the MM-1 Marketed!

In fact, even though we have already done the Pre-Clinical and Clinical Trails for the MM-1 in Africa from 1987-1992 (Phases I, II & III), yet we are still seeking Clinical Trials Sponsorship and Volunters for "NEW" MM-1 Clinical Trials, in order to do "NEW" Trials Sponsored by Pharmaceutical, Scientific and Medical Communities. If interested please contact us.

We are trying to get HIV Groups & Organizations, Medical & Pharmaceutical Institutions & Universities and the Medical & Scientific Communities aware, informed and interested in MM-1, so they can consider and help to Sponsor the MM-1 Clinical Trials, in order to assist those Persons with HIV/AIDS to obtain the MM-1 HIV/AIDS Treatment FREE of CHARGE, IF they qualify and are in the sponsored MM-1 Clinical Trials Study.

MM-1 is the alternative, natural, safe and effective treatment for HIV/AIDS, used Internationally, since 1987 on over 10,000 patients. The Pre-Clinical and Clinical Trials Summary Results for MM-1 from 1987-1993 have been done by The Inventor and Developer of MM-1, Prof. Dr. Ahmed Shafik.

MM-1 has been listed in the USA Patent Office, since a USA Patent was applied for in 1989. A Continuation MM-1 Patent Application Review was applied for August 1992, and April 1994, and the MM-1 is still pending USA Patent Approval!

MM-1 is listed in the AmFAR HIV/AIDS Treatment Directory Vol. 2, No. 4, Feb. 1989, Vol. 6, No. 1, Sept. 30, 1992 and Vol. 7, No.4 Jan.10, 1995, The International Directory of HIV Clinical Trials (by The Canadian HIV Trials Network), June, 1992, pages 78 & 79, and AIDS Treatment News, issue #57, May 20, 1988 and issue #189, Dec.17, 1993.

MM-1 is a code name of a product proved to have immunopotentiating properties. It is an in vivo stimulator of natural killer cells, macrophage-mediated cytotoxicity and B cell response.

MM-1 is an antiviral and immunopotentiating drug, which contains active ingredients of amino-acids, peptones and enzymes. MM-1 has a very low toxicity and wide safety margin. It has a stimulating effect on the immune system, both humoral and cellular, producing a significant increase in the total lymphocyte count as well as the B and T lymphocytes.

MM-1 stimulates the hemopoietic and lymphatic systems of the body, causing an increase in hemoglobin, total leukocytic count, neutrophils and lymphocytes, as well as albumin and globulin. The safety studies done on laboratory animals revealed that prolonged administration of MM-1 in different doses up to 9-fold the therapeutic dose did not reveal any toxic effects.

There were no abnormal manifestation of mortality, and the viscera upon examination showed no morphological or histopathologic changes. The MM-1 drug restores the underlying Immunodeficiency in AIDS patients to within normal levels, opportunistic infections improved during MM-1 therapy, with the exception of Kaposi Sarcoma (KS), which is not affected by the drug.

Animal studies demonstrated that MM-1 has no acute, subchronic or chronic toxic effects at doses more than 100 times the maximum human dose. The studies showed also that the drug has no teratogenic mutagenic or carcinogenic effect. Clinical trials 1987-1993 showed no toxic effects for the MM-1 drug. Over 10,000 patients have been treated with MM-1 thus far.

The study results of The Antiviral Effects of MM-1 showed that MM-1 has an inhibitory effect on the replication of many viruses. The effect was examined in culture on DNA and RNA virus group: the inhibitory effect was significant in both groups.

It appears that MM-1 penetrates and destroys the virus cover, thus preventing its adsorption to cell membrane. The animal experiments demonstrated that MM-1 is immunopotentiating and the antiviral action could be related to this property.

The study on The effects of MM-1 on Humoral and Cellular Immunity showed MM-1 to have an immunostimulating property. MM-1 caused a significant increase in the immunoglobulin serum levels. MM-1 also caused an increase in the cellular immunity.

MM-1 also showed a significant increase in both IgG and IgM. the total Lymphocytic count as well as the B and T lymphocytes showed significant increases. These results showed that MM-1 has a stimulating effect on the immune system, both humoral and cellular.

The Hemopoietic Immunomodulating Effects of MM-1 was studied to explore the effect of MM-1 on animals with immunosuppression induced by Chemotherapy.

The results showed that MM-1 could help in the treatment of patients with anergic associated with malignancy and immunodeficiency diseases. MM-1 can also be used in the treatment of the myelo and immuno-suppression status which follows administration of the different chemotherapeutic agents in malignancy.

MM-1 Clinical Trials results showed that there were clinical and immunological improvement, and the drug was well tolerated, with no adverse effects.

In some patients there were minor side effects of: fever, chills, soreness at the injection site and occasional pruritus and sterile abscess at the injection site. The patients showed no side effects or signs of renal, hepatic or cardiac dysfunction that could be attributed to the MM-1 compound.

There was gradual disappearance of the AIDS Related Symptoms such as fever, exhaustion, and cough with pulmonary lesions. The patients soon experienced the feeling of well-being, increased appetite, and within 7 weeks patients had gained weight between 0.7 kg 6.0 kg, with an average of 2.0 kg.

The subcutaneous abscesses healed, pruritus, herpes zoster, genital herpes, neurotoxoplasmosis, lymphadenopathy and pneumonia disappeared.

There is clinically and immunologically evidence that MM-1 therapy is superior to other antiviral treatments. Patients treated with MM-1 had their symptoms of illness associated with AIDS subsided.

The immune system was restored to normal, no side effects, except fever and soreness at the injection site have been encountered.

The Patients were able to return to their work and normal activities of living after treatment with MM-1, thus allowing the Persons with HIV/AIDS and their families to live out their lives in peace, comfort and with dignity!

Perhaps you may be interested, and perhaps you may even be willing to assist us as well.

Would you be willing to Volunteer and assist us in getting HIV Groups, Agencies and Organizations, Medical and Pharmaceutical Institutions, Universities and the Medical and Scientific Communities aware, informed and interested in MM-1, so that they can Sponsor the MM-1 Clinical Trials, in order to assist Persons with HIV/AIDS to obtain FREE Medical Treatment with The MM-1, If they qualify for the Clinical Trials Study? If so, then please contact us. Thank you very much.

Regards,
MICA, INC.

FOR MORE INFORMATION PLEASE VISIT OUR SITE AT:

http://www.aidshivtreatment.bizland.com

and

http://www.geocities.com/mm1eg

OR EMAIL US AT : mm1eg@aidshivtreatment.bizland.com


Post Extras: Remind Me!   Notify Moderator  
Pages: 1


What's New at TheBody.com

Additional Information
0 registered and 1 anonymous users are browsing this forum.

Moderator:  TheBody, bogart, crabman, riverprincess 

Permissions
      You cannot start new topics
      You cannot reply to topics
      HTML is enabled
      UBBCode is enabled

Thread views: 4289

 
Jump to

Contact Us | Privacy Statement The Body

*
UBB.threads™ 6.2.3